Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion type Assertion NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_head.
- NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion description "[Approximately 50% of glioblastomas (GBMs) are characterized by overexpression of the epidermal growth factor receptor (EGFR) and EGFR gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_provenance.
- NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion evidence source_evidence_literature NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_provenance.
- NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion SIO_000772 19204207 NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_provenance.
- NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion wasDerivedFrom gad-20150221 NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_provenance.
- NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_assertion wasGeneratedBy ECO_0000203 NP109687.RAv-q4PRxzgC6eol8NuLy9eKP-3EAWKqFV6g1A4W2uDD4130_provenance.